FDA import alert status
China · appears on 1 FDA import alert
1
Red-list alerts
0
Green-list alerts
0
Yellow-list alerts
China
Country
2018-04-04
Latest indexed date
As published on the official FDA import alert list, this firm appears on 1 red list. A red-list firm is subject to Detention Without Physical Examination (DWPE): FDA can detain its shipments at the border automatically, without sampling. The burden shifts to the importer to prove the goods are not violative.
Import alert status changes over time. Import Alert Radar re-checks the official FDA source every day; the entries below reflect the latest refresh (2026-09-04 UTC).
Source-linked FDA evidence
The current dataset ties this firm to 1 FDA import alert, 1 published address and 2 product descriptions. Each detail below stays attached to the alert row where FDA published it; dataset refreshed 2026-09-04 UTC.
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
New · one-time pilot
Get a source-linked Supplier Evidence Snapshot for NUSPOWER GREATSUN (GUANGDONG) BIOTECHNOLOGY CO., LTD: current red / green-list status, every matching FDA import alert, dates, official links and the dataset timestamp — prepared for your supplier file.
Informational evidence record, not legal advice or an FDA/FSVP certification.
Put this supplier on watch: we re-check the official FDA import alert list daily and email you the day NUSPOWER GREATSUN (GUANGDONG) BIOTECHNOLOGY CO., LTD is added to a red list — or removed from one — so a detained shipment never catches you by surprise.
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Is NUSPOWER GREATSUN (GUANGDONG) BIOTECHNOLOGY CO., LTD in your supply chain? Alert me when this supplier's FDA status changes — $19/mo
